Abstract:
A mobile terminal may be provided that includes a squeeze sensor disposed at a lateral surface of a housing to sense a pressure greater than a predetermined value being applied thereto; and a controller configured to change the location of an object displayed on a display based on a pressure applied position when the sensed pressure is greater than a predetermined value.
Abstract:
The present invention relates to a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polyamino acid chain block, wherein the hydrophilic polymer chain block is covalently bound to one end of the main chain of the polyamino acid chain block, and the hydrophobic group is covalently bound to the side chains of not less than 10% and not greater than 70% of amino acid repeating units in the polyamino acid chain block. This block copolymer forms a stable aggregate with siRNA, a small-molecule nucleic acid, under a physiological condition.
Abstract:
Disclosed are compounds of the formula: and compounds of the formula: wherein R1, R2, R3, R4, R5, u and v are as defined herein. Also disclosed are methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol using compounds of formula I or IIA.
Abstract:
A terminal is provided. the terminal includes: at least one body sensor; at least one wireless communication module; a display unit; a memory for storing a program that processes at least one body signal detected by the at least one body sensor; and a control unit for executing the memory.
Abstract:
The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below.
Abstract:
Disclosed herein is a prismatic battery having an electrode assembly mounted in a prismatic battery case, wherein an electrolyte injection hole formed in a base plate mounted to an open upper end of the battery case is constructed such that an inside upper end of the electrolyte injection hole is formed in a downward taper (incline) structure, and a metal ball is forcibly inserted into the electrolyte injection hole such that the metal ball is plastically deformed to seal the electrolyte injection hole. The prismatic battery according to the present invention provides high coupling force between the metal ball and the electrolyte injection hole due to the plastic deformation and forced insertion of the metal ball and high sealability of the electrolyte injection hole. Also, the formation of a groove at the upper end of the forcibly inserted metal ball and the generation of cracks at the interface between the metal ball and the inside surface of the electrolyte injection hole are effectively prevented. Consequently, the present invention has the effect of accomplishing high electrolyte sealability.
Abstract:
Disclosed herein is a prismatic battery having an electrode assembly mounted in a prismatic battery case, wherein an electrolyte injection hole formed in a base plate mounted to an open upper end of the battery case is constructed such that an inside upper end of the electrolyte injection hole is formed in a downward taper (incline) structure, and a metal ball is forcibly inserted into the electrolyte injection hole such that the metal ball is plastically deformed to seal the electrolyte injection hole. The prismatic battery according to the present invention provides high coupling force between the metal ball and the electrolyte injection hole due to the plastic deformation and forced insertion of the metal ball and high sealability of the electrolyte injection hole. Also, the formation of a groove at the upper end of the forcibly inserted metal ball and the generation of cracks at the interface between the metal ball and the inside surface of the electrolyte injection hole are effectively prevented. Consequently, the present invention has the effect of accomplishing high electrolyte sealability.
Abstract:
A traveling control method, medium, and apparatus for autonomous navigation. The traveling control method of controlling an autonomous navigation machine, having at least on the right and left sides thereof at least first and second receivers that receive a radio signal transmitted from a transmitter disposed at a specific position in a traveling area, the method includes allowing at least one of the first and second receivers to receive the radio signal, recognizing a command included in the received radio signal, acquiring data indicating a size of a recognizable area reached by the radio signal and a position of the transmitter while the autonomous navigation machine moves along the border of the recognizable area, and executing the recognized command in the recognizable area.
Abstract:
The present invention provides an efficient delivery system for a nucleic acid, more specifically, a cationic poly(amino acid) that has a side chain having a plurality of different amine functional groups in a moiety including a cationic group and that has a hydrophobic group introduced into part of the side chain, and a polyion complex (PIC) of the poly(amino acid) and an oligo- or polynucleotide.
Abstract:
Disclosed is a polymer composite (polyplex) that contains nucleic acid, a cationic polymer, and an anionic polymer. The anionic polymer covers the surface of the composite comprising the cationic polymer and nucleic acid, has a negative charge at neutral pH, and can change so as to have a positive charge at mildly acidic pH.